https://www.globenewswire.com/news-release/2026/4/17/3276461/0/en/Zentalis-Pharmaceuticals-To-Present-Azenosertib-Preclinical-Data-in-Triple-Negative-Breast-Cancer-and-Real-World-Analysis-of-Unmet-Need-in-Cyclin-E1-Positive-Ovarian-Cancer-at-AACR.html
Zentalis Pharmaceuticals To Present Azenosertib Preclinical
Preclinical data show encouraging activity of azenosertib combinations in ADC-resistant TNBC, supporting the potential for pipeline expansion beyond...
pharmaceuticalspresentpreclinical